National Institutes of Health logo
NIH Phase 1 Exploratory/Developmental Cooperative Agreement (UG3)

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention

Funds stroke trials and biomarker studies run inside NIH's national StrokeNet β€” with its coordinating centres doing recruitment and data.

OpenNational Institutes of HealthUnited States

NIH runs a national stroke trials network, and this notice funds work carried out inside it.

Three kinds of study are wanted. Multi-site exploratory and confirmatory clinical trials of promising interventions. Biomarker or outcome-measure validation studies that are immediately preparatory to a trial in stroke prevention, treatment or recovery. And ancillary studies that add scientific aims to tr…

Multi-site exploratory and confirmatory clinical trials of stroke interventions, biomarker and outcome-measure validation studies immediately preparatory to such trials, and ancillary studies adding aims to active StrokeNet studies. All conducted within the NIH StrokeNet infrastructure.

CycleiHow often this grant runs β€” e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.19 Nov 2026
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.β€”
Award typeiThe form of funding β€” grant, equity, loan, tax credit, etc.Cooperative agreement
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.β€”
Funding pooliThe total budget available across all awards in this round.β€”

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: PAR-25-052Source: www.grants.gov